These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24142528)

  • 1. Meta-analysis of the association between NQO1 Pro187Ser polymorphism and colorectal cancer in Asians.
    Zhao H; Zhu F; Sun J; Meng X
    Tumour Biol; 2014 Mar; 35(3):2111-6. PubMed ID: 24142528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and risk of bladder cancer.
    Zhang H; Wen X; Lu X; Zhang H
    Tumour Biol; 2013 Dec; 34(6):3377-81. PubMed ID: 23873104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of NAD(P)H quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and risk of colorectal adenoma and colorectal cancer in Caucasians: a meta-analysis.
    Chen J; Lin Y; Zhang R; Huang ZJ; Pan XG
    Arch Med Res; 2012 Jan; 43(1):58-66. PubMed ID: 22306249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-analysis.
    Liu K; Tian H; Yu KZ; Shen WY; Mao ZC; Jin CH; Pan HB; He JX
    Tumour Biol; 2014 Mar; 35(3):2063-8. PubMed ID: 24213850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between NQO1 C609T polymorphism and colorectal cancer risk.
    Wang Y; Zhang G; Luo Y
    Tumour Biol; 2013 Dec; 34(6):4027-32. PubMed ID: 23893397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysis.
    Peng Q; Lu Y; Lao X; Chen Z; Li R; Sui J; Qin X; Li S
    Diagn Pathol; 2014 May; 9():100. PubMed ID: 24884893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.
    Chao C; Zhang ZF; Berthiller J; Boffetta P; Hashibe M
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):979-87. PubMed ID: 16702380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between NQO1 Pro187Ser polymorphism and urinary system cancer susceptibility: a meta-analysis of 22 studies.
    Zhang Y; Yang D; Zhu JH; Chen MB; Shen WX; He J
    Cancer Invest; 2015 Mar; 33(2):39-40. PubMed ID: 25608636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between NQO1 Pro187Ser polymorphism and bladder cancer susceptibility: a meta-analysis of 15 studies.
    Yang S; Jin T; Su HX; Zhu JH; Wang DW; Zhu SJ; Li S; He J; Chen YH
    PLoS One; 2015; 10(1):e0116500. PubMed ID: 25602258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence on the association between NQO1 Pro187Ser polymorphism and breast cancer risk in the current studies: a meta-analysis.
    Yuan W; Xu L; Chen W; Wang L; Fu Z; Pang D; Li D
    Breast Cancer Res Treat; 2011 Jan; 125(2):467-72. PubMed ID: 20526805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of NQO1 Pro187Ser polymorphism with the risks for colorectal cancer and colorectal adenoma: a meta-analysis.
    Zhou JY; Shi R; Yu HL; Zheng WL; Ma WL
    Int J Colorectal Dis; 2012 Aug; 27(8):1123-4. PubMed ID: 22116627
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a meta-analysis.
    Ding R; Lin S; Chen D
    Int J Colorectal Dis; 2012 Jul; 27(7):885-92. PubMed ID: 22215148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of the NAD(P)H: quinine oxidoreductase 1 gene 609 C>T polymorphism with esophageal cancer risk.
    Wang Z; Hu J; Zhong J
    DNA Cell Biol; 2012 Apr; 31(4):560-7. PubMed ID: 22017531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "NQO1 Gene C609T Polymorphism (dbSNP: rs1800566) and Digestive Tract Cancer Risk: A Meta-Analysis.".
    Yadav U; Kumar P; Rai V
    Nutr Cancer; 2018; 70(4):557-568. PubMed ID: 29652514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis.
    Gong M; Yi Q; Wang W
    Tumour Biol; 2013 Oct; 34(5):2551-6. PubMed ID: 23749485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis.
    Lou Y; Li R; Xiong L; Gu A; Shi C; Chu T; Zhang X; Gu P; Zhong H; Wen S; Han B
    Tumour Biol; 2013 Dec; 34(6):3967-79. PubMed ID: 23852860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effects of NQO1 Pro187Ser or SULT1A1 Arg213His polymorphism and smoking on bladder cancer risk: Two meta-analyses.
    Wang XC; Wang J; Tao HH; Zhang C; Xu LF
    Int J Occup Med Environ Health; 2017 Jul; 30(5):791-802. PubMed ID: 28589969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population.
    Sameer AS; Shah ZA; Syeed N; Rasool R; Afroze D; Siddiqi MA
    Asian Pac J Cancer Prev; 2010; 11(1):209-13. PubMed ID: 20593958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis demonstrates that the NAD(P)H: quinone oxidoreductase 1 (NQO1) gene 609 C>T polymorphism is associated with increased gastric cancer risk in Asians.
    Zhang Y; Wang ZT; Zhong J
    Genet Mol Res; 2012 Aug; 11(3):2328-37. PubMed ID: 22911602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAD(P)H quinone oxidoreductase 1 (NQO1) genetic C609T polymorphism is associated with the risk of digestive tract cancer: a meta-analysis based on 21 case-control studies.
    Yang FY; Guan QK; Cui YH; Zhao ZQ; Rao W; Xi Z
    Eur J Cancer Prev; 2012 Sep; 21(5):432-41. PubMed ID: 22387672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.